Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Monte Rosa Therapeutics, Inc. is seeking a senior toxicologist to direct nonclinical safety and toxicology programs across discovery to development. You will design, oversee, and interpret studies, coordinating with CROs and internal scientists to derisk candidates and support regulatory filings.
This IC role emphasizes collaboration with biology, chemistry, and DMPK teams, data interpretation, documentation quality, and growth into regulatory toxicology for INDs/NDAs.
Monte Rosa Therapeutics is searching for a toxicologist to direct nonclinical safety and toxicology work for programs to enable drug candidates during all phases from discovery through development.
This individual contributor role will contribute to the research and development strategy and will report to the Senior Director of Nonclinical Development, by designing, conducting or overseeing studies, analyzing and interpreting results, ensuring appropriate quality of documentation and record keeping, in close collaboration with other scientists, for a broad range of nonclinical activities:- in silico, in vitro, ex vivo, and in vivo studies;- non-GLP and GLP studies;- nonclinical pharmacology, PK/PD, and toxicology studies, mainly conducted at Contract Research Organizations (CROs).
The toxicologist will also support global regulatory activities related to nonclinical sections of filings including Investigational New Drugs (INDs), annual reports, Investor Brochures (IBs) and New Drug Applications (NDAs), and annual reports. The toxicologist will interact directly with multidisciplinary teams including biology, medicinal chemistry, CMC, DMPK, clinical science, in research and development projects, to move discovery candidates into development. Introduction and growth into regulatory toxicology will be an extension of this position. The ideal candidate will be able to help evolve Monte Rosa’s hit identification and hit-to-lead endeavors through embracing novel assay technologies, enhancing overall process and actively drive internal and external partnerships.